Evidence map›Paper›PMID 35308177›Full record

ArticleOxidative medicine and cellular longevity2022

Corrigendum to "Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation".

Dandong Fang, Yongbin Wang, Ziyue Zhang, Donghai Yang, Daqian Gu, Bo He, Xiaoqun Zhang, Duofen He, HongYong Wang, Pedro A Jose and 2 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Potential role of SIRT1 in cell ferroptosis.Frontiers in cell and developmental biology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Dandong FangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.ORCID https://orcid.org/0000-0003-0482-7753
Yongbin WangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Ziyue ZhangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Donghai YangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Daqian GuDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Bo HeDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Xiaoqun ZhangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Duofen HeDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
HongYong WangDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.
Pedro A JoseDivision of Renal Disease & Hypertension, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA.
Yu HanDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.ORCID https://orcid.org/0000-0002-3369-7655
Chunyu ZengDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China.ORCID https://orcid.org/0000-0003-0173-5028
Army Medical University · CNGeorge Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2021/2999296.].

Identifiers

PMID35308177
PMCPMC8930271
OpenAlexW4221014538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.